Charles Ryhee
Stock Analyst at TD Cowen
(2.54)
# 2,073
Out of 4,814 analysts
25
Total ratings
52.38%
Success rate
0.47%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $67.28 | +18.91% | 5 | Nov 25, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $10.80 | +29.63% | 6 | Oct 22, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $697.08 | -6.47% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $137.91 | +23.27% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $8.97 | +557.75% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $134.68 | -46.54% | 1 | Aug 16, 2022 | |
| OTRK Ontrak | Downgrades: Underperform | $3,150 → $810 | $1.41 | +57,346.81% | 2 | Aug 20, 2021 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $6.83 | +2,652.56% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $12.35 | +134.82% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $67.28
Upside: +18.91%
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $10.80
Upside: +29.63%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $697.08
Upside: -6.47%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $137.91
Upside: +23.27%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $8.97
Upside: +557.75%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $134.68
Upside: -46.54%
Ontrak
Aug 20, 2021
Downgrades: Underperform
Price Target: $3,150 → $810
Current: $1.41
Upside: +57,346.81%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $6.83
Upside: +2,652.56%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $12.35
Upside: +134.82%